References
- Liabeuf S, Drüeke TB, Massy ZA. Protein-bound uremic toxins: new insight from clinical studies. Toxins (Basel). 2011;3(7):911–919
- Mandal A, Das K, Roy S, et al. In vivo assessment of bacteriotherapy on acetaminophen-induced uremic rats. J Nephrol. 2013;26(1):228–236
- Friedman EA. Can the bowel substitute for the kidney in advanced renal failure?. Curr Med Res Opin. 2009;25(8):1913–1918
- Ranganathan N, Patel BG, Marczely J, et al. In vitro and in vivo assessment of intraintestinal bacteriotherapy in chronic kidney disease. ASAIO J. 2006;52(1):70–79
- Ranganathan N, Friedman EA, Tam P, et al. Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada. Curr Med Res Opin. 2009;25(8):1919–1930
- Zhang S, Li D, Tian K, et al. Development of a recombinant ureolytic Lactococcus Lactis for urea removal. Artif Cells Blood Substit Immobil Biotechnol. 2009;37(6):227–234
- Zhen L, Jianhua C. Uricase producing strain. Cloning and expression. J Pharm Univ. 2005;36(5):464–466
- Tianhong W, ed. Microbiological Principles and Techniques of Molecular Breeding. Beijing: Chemical Industry Press; 2005
- Lu Ye L, Shi Bells A. Lactobacillus bulgaricus and more resistant mutation. Dairy Sci Technol. 2010;(12):6–10
- Xiaoli D, Haiying A, Haihong Z, et al. Fosfomycin producing strains directed mutagenesis breeding. Biotechnology. 2009;19(4):25–28